38 results on '"Wu, Jun-Jun"'
Search Results
2. Application of Fracture Density Prediction Method Based on Multi-layer Feedforward Neural Network in Shale Oil of Fengcheng Formation, Mabei, Junggar Basin
3. STING and TLR7/8 agonists-based nanovaccines for synergistic antitumor immune activation
4. A chitosan-mediated inhalable nanovaccine against SARS-CoV-2
5. The coupling effect of cellulose nanocrystal and strong shear field achieved the strength and toughness balance of Polylactide
6. A hybrid cooling system to enable adhesion-free heat recovery from centrifugal granulated slag particles
7. Black phosphorous nanosheet: A novel immune-potentiating nanoadjuvant for near-infrared-improved immunotherapy
8. An Adjustable Adjuvant STINGsome for Tailoring the Potent and Broad Immunity Against SARS‐CoV‐2 and Monkeypox Virus via STING and Necroptosis
9. Cold experiment of slag centrifugal granulation by rotary atomizer: Effect of atomizer configuration
10. Cyclic Dinucleotide Self-Assembled Nanoparticles as a Carrier-Free Delivery Platform for STING-Mediated Cancer Immunotherapy
11. CASTING: A Potent Supramolecular Strategy to Cytosolically Deliver STING Agonist for Cancer Immunotherapy and SARS-CoV-2 Vaccination
12. Centrifugal granulation performance of liquid with various viscosities for heat recovery of blast furnace slag
13. Cover Picture
14. Overcoming STING Agonists Barriers: Peptide, Protein, and Biomembrane‐based Biocompatible Delivery Strategies
15. Denoising Analysis and Processing Methods of Distributed Acoustic Sensing (DAS) Vertical Seismic Profiling (VSP) Data
16. A novel STING agonist for cancer immunotherapy and a SARS-CoV-2 vaccine adjuvant
17. Regulation of liquid–liquid phase separation with focus on post-translational modifications
18. Pam3CSK4-CDGSF Augments Antitumor Immunotherapy by Synergistically Activating TLR1/2 and STING
19. Overcoming STING Agonists Barriers: Peptide, Protein, and Biomembrane‐based Biocompatible Delivery Strategies.
20. Adopting STING agonist cyclic dinucleotides as a potential adjuvant for SARS-CoV-2 vaccine
21. Regulation of Immune Activation by Optical Control of TLR1/2 Heterodimerization
22. Fully Synthetic Invariant NKT Cell-Dependent Self-Adjuvanting Antitumor Vaccines Eliciting Potent Immune Response in Mice
23. Agonists and inhibitors of the STING pathway: Potential agents for immunotherapy
24. Synthesis of new 4-aryloxy-N-arylanilines and their inhibitory activities against succinate-cytochrome c reductase
25. Data for the synthesis of new 4-aryloxy-N-arylanilines as potent succinate-cytochrome c reductase inhibitors
26. Pam3CSK4‑CDGSF Augments Antitumor Immunotherapy by Synergistically Activating TLR1/2 and STING.
27. Agonists and inhibitors of the STING pathway: Potential agents for immunotherapy.
28. Targeting STING with cyclic di-GMP greatly augmented immune responses of glycopeptide cancer vaccines
29. Photonic crystal fiber polarization filter with two large apertures coated with gold layers
30. Design and construction of mobile chronic diseases management system
31. Self-Assembled Nano-Immunostimulant for Synergistic Immune Activation
32. Quantifying Einstein-Podolsky-Rosen steering and expanding the scope of steerability of the two qubit state
33. Fully Synthetic Invariant NKT Cell-Dependent Self-Adjuvanting Antitumor Vaccines Eliciting Potent Immune Response in Mice
34. Pam3CSK4-CDGSFAugments Antitumor Immunotherapy by Synergistically Activating TLR1/2 and STING
35. Synthesis of 2H-pyrrolo[3,4-C]quinoline via an Aldol/Van Leusen/Staudinger/aza-Wittig sequence
36. Energy–environment–economy evaluations of commercial scale systems for blast furnace slag treatment: Dry slag granulation vs. water quenching
37. Front Cover: Overcoming STING Agonists Barriers: Peptide, Protein, and Biomembrane‐based Biocompatible Delivery Strategies (Chem. Asian J. 6/2022).
38. Pam 3 CSK 4 -CDG SF Augments Antitumor Immunotherapy by Synergistically Activating TLR1/2 and STING.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.